Catalyst Pharmaceuticals (CPRX) Receivables - Net (2019 - 2026)
Catalyst Pharmaceuticals' Receivables - Net came in at $130.83 million for Q1 2026, up 83.6% from $71.27 million a year earlier and up 3.4% from the prior quarter.
Catalyst Pharmaceuticals (CPRX) Receivables - Net (2019 - 2026) Analysis & Trends
At the end of FY2025, Catalyst Pharmaceuticals' Receivables - Net was $126.48 million, up 93.2% from FY2024.
- Receivables - Net has increased in each of the last five years, with a five-year compound annual growth rate of 84.1% (FY2020 to FY2025).
- Going back by year, Receivables - Net was $65.48 million in FY2024 (+22.4%), $53.51 million in FY2023 (+412.6%), $10.44 million in FY2022 (+57.7%) and $6.62 million in FY2021 (+10.6%).
- The Q1 2026 figure represents the highest quarterly Receivables - Net in data going back to Q1 2019.
- Year-over-year, Receivables - Net has increased for 19 consecutive quarters, with growth averaging 46.2% over the last eight quarters.
- The fastest year-over-year change in Receivables - Net over five years came in Q3 2023 (growth of 414.6%), and the weakest in Q2 2021 (a decline of 7.0%).
- Business Quant data shows CPRX's Receivables - Net at $126.48 million (Q4 2025), $106.41 million (Q3 2025) and $65.86 million (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 1.04 Bn | 134.92 Mn |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 130.83 Mn |
| Dec 31, 2025 | 126.48 Mn |
| Sep 30, 2025 | 106.41 Mn |
| Jun 30, 2025 | 65.86 Mn |
| Mar 31, 2025 | 71.27 Mn |
| Dec 31, 2024 | 65.48 Mn |
| Sep 30, 2024 | 58.27 Mn |
| Jun 30, 2024 | 57.17 Mn |
| Mar 31, 2024 | 60.49 Mn |
| Dec 31, 2023 | 53.51 Mn |
| Sep 30, 2023 | 48.05 Mn |
| Jun 30, 2023 | 42.80 Mn |
| Mar 31, 2023 | 33.40 Mn |
| Dec 31, 2022 | 10.44 Mn |
| Sep 30, 2022 | 9.34 Mn |
| Jun 30, 2022 | 9.59 Mn |
| Mar 31, 2022 | 10.55 Mn |
| Dec 31, 2021 | 6.62 Mn |
| Sep 30, 2021 | 6.63 Mn |
| Jun 30, 2021 | 6.29 Mn |
Catalyst Pharmaceuticals Receivables - Net API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables-net&ticker=CPRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables-net", "ticker": "CPRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=receivables-net&ticker=CPRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();